Tech & Pharma

ZAI Lab Licenses Respiratory Disease Drugs From Sanofi ZAI Lab Licenses Respiratory Disease Drugs From Sanofi
  • August 22nd, 2014
  • ZAI Lab has acquired the license for two pre-clinical drugs for chronic respiratory diseases.

» Read More...

Tech & Pharma

ZAI Lab Licenses Respiratory Disease Drugs From Sanofi

ZAI Lab Licenses Respiratory Disease Drugs From Sanofi

ZAI Lab has acquired the license for two pre-clinical drugs for chronic respiratory diseases.

PW Medtech Acquires Tianxinfu For US$130 Million

PW Medtech Acquires Tianxinfu For US$130 Million

PW Medtech expands its capabilities in medical devices with the acquisition of Beijing Tianxinfu Medical Appliance Co.

Fosun Commits US$111 Million To Partnership With Public Hospital

Fosun Commits US$111 Million To Partnership With Public Hospital

The partnership between Fosun and Taizhou Muncipal Hospital will add approximately 2,000 new hospital beds to serve the residents of Taizhou.

Celltrion Files For FDA Approval For Biosimilar Drug

Celltrion Files For FDA Approval For Biosimilar Drug

Celltrion predicts that it is one year away from approval for Remsima®, a biosimilar based on an originator drug from Janssen Biotech.

Fujitsu & NCKU Sign Big Data Platform MOU

Fujitsu & NCKU Sign Big Data Platform MOU

The National Cheng Kung University and Fujitsu will develop a cloud computing platform for big data analysis in agriculture and genomics research.

Agreen Acquisition Enhances CBMG’s T Cell Portfolio

Agreen Acquisition Enhances CBMG’s T Cell Portfolio

China’s Cellular Biomedicine Group acquires Agreen for US$3.38 million in cash in addition to stock units.

3SBio Licenses DiNonA’s Anti-Leukemia Treatment

3SBio Licenses DiNonA’s Anti-Leukemia Treatment

3SBio and DiNonA will develop Leukotuximab, an anti JL-1 antibody indicated for the treatment of acute leukemia.

Astellas & Cancer Research UK Team Up In Fight Against Cancer

Astellas & Cancer Research UK Team Up In Fight Against Cancer

The partnership between Astellas and Cancer Research Technology will begin with the development of drugs for pancreatic cancer targeting autophagy.

Baxter Expands Biologics In Singapore

Baxter Expands Biologics In Singapore

Baxter’s biologic facility in Singapore has been approved by the European Medicines Agency to supply products for hemophiliacs.

Solasia Acquires License For ZIOPHARM’s Darinaparsin

Solasia Acquires License For ZIOPHARM’s Darinaparsin

ZIOPHARM could receive up to US$72.2 million from Solasia for the anti-cancer drug darinaparsin.